Doctor profile · Federal record
Dr. Dahlia Carr, MD
Rheumatology Physician (CMS: Rheumatology) · Beverly Hills, CA
- NPI 1356368930
- Accepts Medicare
- MIPS 89.9 / 100 · 2023
- 25 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
150 N Robertson Blvd, Ste 224
Beverly Hills, CA 902112142
(310) 659-5905
fax (310) 659-1209
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- October 24, 2025
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- California #A80951
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1356368930. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
43,580
Distinct HCPCS
10
Medicare allowed
$831,020
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3111 |
Injection, romosozumab-aqqg, 1 mg | 20,122 | 17 | $10 | |
J0897 |
Injection, denosumab, 1 mg | 19,140 | 182 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 749 | 368 | $139 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 308 | 184 | $85 | |
96372 |
Injection of drug or substance under skin or into muscle | 242 | 179 | $16 | |
36415 |
Insertion of needle into vein for collection of blood sample | 228 | 144 | $8 | |
85651 |
Red blood cell sedimentation rate, to detect inflammation, non-automated | 215 | 137 | $4 | |
82248 |
Bilirubin level, direct | 214 | 137 | $5 | |
84100 |
Phosphate level | 214 | 137 | $5 | |
84550 |
Uric acid level, blood | 214 | 136 | $4 |
In context: peer comparison
Among 7 peers in this city , average services per provider: 1,781. This provider delivers 24× the peer median.Open Payments
Industry payments received
All-time total
$2,249
Transactions
87
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen Inc. | 26 | $611.59 | |
| ABBVIE INC. | 18 | $460.17 | |
| GlaxoSmithKline, LLC. | 12 | $286.28 | |
| Mallinckrodt Hospital Products Inc. | 7 | $221.19 | |
| Janssen Biotech, Inc. | 7 | $213.15 | |
| Radius Health, Inc. | 6 | $161.90 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $51.14 | |
| AstraZeneca Pharmaceuticals LP | 2 | $39.21 | |
| UCB, Inc. | 1 | $36.64 | |
| Kiniksa Pharmaceuticals International, plc | 1 | $32.34 | |
| Organon Llc | 1 | $27.68 | |
| PFIZER INC. | 1 | $27.01 | |
| Genentech USA, Inc. | 1 | $20.62 | |
| DePuy Synthes Sales Inc. | 1 | $20.52 | |
| Novartis Pharmaceuticals Corporation | 1 | $20.22 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
803
Patients
130
Total drug cost
$23,999
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Gabapentin | Generic | 110 | 24 | $1,412 |
| Methotrexate (Methotrexate Sodium) | Brand | 101 | 23 | $3,696 |
| Hydroxychloroquine Sulfate | Generic | 96 | 21 | $5,533 |
| Prednisone | Generic | 74 | 11 | $898 |
| Duloxetine Hcl | Generic | 72 | 18 | $1,782 |
| Meloxicam | Generic | 67 | 19 | $273 |
| Raloxifene Hcl | Generic | 55 | 0 | $4,549 |
| Cyclobenzaprine Hcl | Generic | 50 | 14 | $465 |
| Diclofenac Sodium | Generic | 31 | 0 | $987 |
| Sulfasalazine Dr (Sulfasalazine) | Brand | 28 | 0 | $1,343 |
Hospital affiliations
Frequently asked questions
What is Dr. Dahlia Carr's medical specialty?
Dr. Dahlia Carr practices Rheumatology Physician in Beverly Hills, CA.
Where does Dr. Dahlia Carr practice?
Dr. Dahlia Carr practices at 150 N Robertson Blvd, Beverly Hills, CA 902112142. Office phone: 3106595905.
What is Dr. Dahlia Carr's NPI?
Dr. Dahlia Carr's National Provider Identifier (NPI) is 1356368930, issued by NPPES.
Does Dr. Dahlia Carr accept Medicare assignment?
Yes. Dr. Dahlia Carr accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Dahlia Carr commonly perform?
Top Medicare-reported procedures in 2023: Injection, romosozumab-aqqg, 1 mg (HCPCS J3111); Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.